AVEO Pharmaceuticals, Inc. (AVEO)

[stockguard]

MakinBank

I posted this on the thread last night after market close:

Anyone that read it was able to get out or in using after hours trading......

$AVEO Oncology Shifts TIVO-3 Topline Data for Renal Cancer to Q4 2018 -
Stock Slumps 32% After-Hours

04:39 PM EDT, 07/16/2018 (MT Newswires) -- AVEO Oncology (AVEO) said on Monday it now expects to report TIVO-3 topline data in Q4 of 2018 due to the progression-free survival events (PFS) events occurring slower than forecasted, combined with some patients being removed from the PFS event count, which often occurs once the data cleaning and review process is initiated.

Prior to reporting data, Aveo said it plans to announce when 255 PFS events have occurred and topline data analysis for the trial has been initiated.

The company had expected to report topline data from the TIVO-3 trial, its phase 3 trial of tivozanib as a third-line treatment for advanced renal cell carcinoma, 6-8 weeks after the trial records 255 PFS events.

Price: 1.93, Change: -0.92, Percent Change: -32.28